Arsenal Capital Partners, a New York-based private equity firm, has acquired Para-Chem Southern, a provider of adhesives, coatings and polymers. Concurrent with the transaction, Para-Chem will be merged with Arsenal’s platform investment, Royal Adhesives and Sealants, announced two weeks ago.  Headquartered in South Carolina, Para-Chem offers adhesives, coatings, polymers, surfactants

Edwards, the vacuum technology group, has decided to pursue an initial public offering during the course of 2011. The decision has been made in conjunction with its leading shareholders, CCMP Capital and Unitas Capital. The decision to pursue an IPO follows a period of growth for the group, which is

Darwin Private Equity has entered into an agreement to sell Maxinutrition Group to GlaxoSmithKline for GBP162m. The transaction is subject to approval from the Office of Fair Trading. Maxinutrition, the parent company of Maximuscle, Maxifuel and Maxitone, is a European sports nutrition company. The sale of Maxinutrition is Darwin’s first

EFG Hermes, an investment bank in the Arab world, is co-sponsoring the PPP Investment Summit Egypt. The summit, presented by Egypt’s Ministry of Finance, focuses on new public-private partnership opportunities for investors in Egypt’s infrastructure sector. Key officials from the ministries of finance, transport, housing and investment along with premier

Legal practice Norton Rose has advised UK private equity fund Impax Asset Management on the planned purchase of Epuron’s wind development and operating business in Germany and France. Epuron is a subsidiary of German TecDax-listed solar system manufacturer Conergy. The purchase agreement was signed on 9 December 2010. The financial

A private equity survey of general partners and limited partners by bfinance, a financial services consulting firm, shows a fall in expected internal rate of returns of five to ten per cent over the coming years.  Combined with expectations by over 81 per cent of limited partners of higher dispersion

TYRX, a company dedicated to the commercialisation of implantable medical devices designed to help reduce surgical-site infections associated with pacemakers and defibrillators, has raised USD20m in venture capital funding. The funding was led by new investor HLM Venture Partners, along with previous investors Clarus Ventures and Pappas Ventures. The financing

Matrix Private Equity Partners has invested in the GBP4m management buy-out of Faversham House Group. Faversham is a multi-media business that publishes B2B magazines such as Utility Week, Europe’s largest environmental website www.edie.net and stages the UK’s no.1 environmental exhibition, SustainabilityLive!. Matrix is investing GBP1.75m and will take a significant

Roark Capital Group, an Atlanta-based private equity firm, has acquired Atkins Nutritionals, a weight control and nutrition brand. Atkins’ management team, led by chief executive Monty Sharma, will remain with the business and invested alongside Roark Capital in the transaction. Terms of the transaction were not released. The Atkins Nutritional